Trastuzumab Terminated Phase 2 Trials for HER-2 Gene Amplification / Gastroesophageal Junction Cancer / Malignant Neoplasm of Stomach / Esophagus Cancer Treatment

TerminatedTreatment2 IdentifierTitleDrugs
NCT01774851A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach
NCT02005484A Study of Herceptin (Trastuzumab) in Patients With Metastatic or Advanced Gastric Cancer With Disease Progression